Publication
Characterization of mitochondrial proteome in a severe case of ETF-QO deficiency
| dc.contributor.author | Rocha, H. | |
| dc.contributor.author | Ferreira, R. | |
| dc.contributor.author | Carvalho, J. | |
| dc.contributor.author | Vitorino, R. | |
| dc.contributor.author | Santa, C. | |
| dc.contributor.author | Lopes, L. | |
| dc.contributor.author | Gregersen, N. | |
| dc.contributor.author | Vilarinho, L. | |
| dc.contributor.author | Amado, F. | |
| dc.date.accessioned | 2012-10-24T16:40:09Z | |
| dc.date.available | 2012-10-24T16:40:09Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | Multiple acyl-CoA dehydrogenase deficiency (MADD) is a mitochondrial fatty acid oxidation disorder caused by mutations that affect electron transfer flavoprotein (ETF) or ETF:ubiquinone oxidoreductase (ETF-QO) or even due to unidentified disturbances of riboflavin metabolism. Besides all the available data on the molecular basis of FAO disorders, including MADD, the pathophysiological mechanisms underlying clinical phenotype development, namely at the mitochondrial level, are poorly understood. In order to contribute to the elucidation of these mechanisms, we isolated mitochondria from cultured fibroblasts, from a patient with a severe MADD presentation due to ETF-QO deficiency, characterize its mitochondrial proteome and compare it with normal controls. The used approach (2-DE-MS/MS) allowed the positive identification of 287 proteins in both patient and controls, presenting 35 of the significant differences in their relative abundance. Among the differentially expressed are proteins associated to binding/folding functions, mitochondrial antioxidant enzymes as well as proteins associated to apoptotic events. The overexpression of chaperones like Hsp60 or mitochondrial Grp75, antioxidant enzymes and apoptotic proteins reflects the mitochondrial response to a complete absence of ETF-QO. Our study provides a global perspective of the mitochondrial proteome plasticity in a severe case of MADD and highlights the main molecular pathways involved in its pathogenesis. | por |
| dc.identifier.citation | J Proteomics. 2011 Dec 10;75(1):221-8. Epub 2011 May 7 | por |
| dc.identifier.issn | 1874-3919 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/1054 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | European Proteomics Association (EuPA) / Elsevier | por |
| dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S1874391911001849 | por |
| dc.subject | Fatty Acid Oxidation | por |
| dc.subject | MADD | por |
| dc.subject | Mitochondrial Proteome | por |
| dc.subject | Doenças Genéticas | por |
| dc.title | Characterization of mitochondrial proteome in a severe case of ETF-QO deficiency | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 228 | por |
| oaire.citation.startPage | 221 | por |
| oaire.citation.title | Journal of Proteomics | por |
| oaire.citation.volume | 75(1) | por |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | article | por |